Top U.S. Marijuana Stocks to Watch Now for a Potential Recovery

Marijuana Stocks to Watch as the Market Prepares for Recovery

The U.S. cannabis market continues to expand rapidly, with expected revenues reaching over $45 billion by 2025. This growth is fueled by rising consumer demand and ongoing state-level legalization. So far, 24 states and Washington, D.C. have legalized adult-use marijuana. Nearly 80% of Americans now live near a dispensary. Although federal reform has faced challenges, momentum continues to build. Most recently, a major legalization proposal in Florida failed to meet the required 60% threshold. However, efforts remain active across other key states. Many investors are now focused on the DEA’s expected rescheduling of cannabis. This move could reduce tax burdens and increase medical research. With this news circulating, top marijuana stocks are showing renewed volatility and opportunity this week.

With market sentiment shifting, traders must stay focused and disciplined. Technical analysis is critical when identifying price trends, breakouts, and support zones. In addition, traders should use stop-loss orders to protect against downside risk. Volatility remains high across cannabis names, so managing position size is essential. When evaluating marijuana stocks, it helps to track volume, recent news, and price structure. Watching how a stock reacts at key levels gives insight into trader sentiment. Moreover, staying updated on federal reform talks can provide early clues for breakout potential. While long-term growth is strong, short-term moves can be fast and unpredictable. By combining risk management with clear trade planning, investors can better capture gains while avoiding steep losses.

The Future of the Cannabis Industry

With legalization efforts gaining momentum, multi-state operators are positioned for significant growth. Among the top stocks to watch this month are Trulieve Cannabis Corp. (TCNNF), Curaleaf Holdings Inc. (CURLF), and Verano Holdings Corp. (VRNOF). These companies offer wide dispensary coverage, steady financials, and long-term potential. Additionally, investors should use technical analysis and solid risk management strategies when entering positions.

While recent pullbacks have created attractive entry points, traders must remain disciplined. Support and resistance levels should be closely monitored to identify key price action. By focusing on cannabis leaders with proven performance and strong cash flows, investors can position themselves ahead of possible policy shifts. Let’s take a closer look at three U.S. marijuana stocks to watch this April.

[Read More] 3 Marijuana Stocks To Buy Now And Sell When The Sectors Up

Top 3 U.S. Marijuana Stocks to Watch in April 2025

  1. Trulieve Cannabis Corp. (OTC: TCNNF)
  2. Curaleaf Holdings Inc. (OTC: CURLF)
  3. Verano Holdings Corp. (OTC: VRNOF)

Trulieve Cannabis Corp. (TCNNF)

Trulieve Cannabis Corp. is a top multi-state operator based in Florida. It has built a dominant footprint across the Southeast. The company’s largest presence is in Florida, where it holds a leading market share. Trulieve also operates in states such as Pennsylvania, Arizona, and Ohio. As of early 2025, Trulieve manages 225 dispensaries across the U.S. The company continues to open new locations as adult-use markets expand. Trulieve recently launched adult-use operations in Ohio and expects more openings in 2025. Its strong retail network helps maintain its customer base and brand recognition. Trulieve’s commitment to growth keeps it ahead of smaller competitors. Its vertical integration strategy also allows for better control over quality and costs. This gives the company a competitive advantage in tight-margin markets. Overall, Trulieve remains a key player in U.S. cannabis retail and production.

Financial Performance

Trulieve reported revenue of $1.2 billion in 2024. This marked a 5% increase from the previous year. The company maintained a gross margin of 60%, signaling efficient cost management. Its adjusted EBITDA reached $420 million, or 35% of total revenue. This shows strong profitability despite pricing pressure across the industry. Trulieve also delivered $271 million in operating cash flow. Free cash flow came in at $150 million. These strong cash flows give the company financial flexibility. Trulieve continues to reduce debt while investing in growth. Capital discipline and cash generation are key strengths. The company is also exploring strategic acquisitions in emerging markets. These financial results show that Trulieve is well-positioned for future growth. Even with regulatory delays, the company’s fundamentals remain solid. Investors looking for strong cannabis stocks with profitability and scale should consider Trulieve this month.

[Read More] 2 Canadian Marijuana Stocks For Your Upcoming Watchlist

Curaleaf Holdings Inc. (CURLF)

Curaleaf Holdings Inc. is one of the largest cannabis companies in the U.S. The company is headquartered in Massachusetts and operates across 17 states. Its largest retail presence is in states like Florida, Arizona, and New Jersey. As of 2025, Curaleaf operates 151 dispensaries nationwide. It also owns 19 cultivation facilities, making it a fully integrated operator. Curaleaf focuses on high-growth, heavily populated markets. This gives it access to a wide customer base and strong brand exposure. The company continues to expand into new adult-use states. It is also positioning itself to benefit from possible federal reform. In 2024, Curaleaf strengthened its retail footprint and refined its product lines. It continues to launch new wellness and THC-infused products across the country. Overall, Curaleaf remains a market leader with national exposure and steady growth plans. It is one of the few cannabis companies with the scale to compete long-term.

Financial Performance

Curaleaf reported $1.34 billion in revenue for 2024. This made it one of the highest-grossing cannabis companies in the U.S. Its gross profit was $639 million, with a gross margin of 48%. Adjusted EBITDA came in at $75 million, with a 23% EBITDA margin. While the company posted a net loss of $71 million, it also reported an adjusted net income of $12 million. Curaleaf held $107 million in cash at year-end. This gives it the liquidity needed for continued expansion. The company remains focused on cost reduction and margin improvement. It has exited underperforming markets and is reallocating resources. Its financials show a commitment to streamlining operations and protecting shareholder value. Despite short-term losses, Curaleaf’s top-line growth and cash reserves support its long-term thesis. Investors should watch for margin expansion and operational updates in 2025.

[Read More] Marijuana Stocks in Focus: U.S. Companies Ready for a Breakout

Verano Holdings Corp. (VRNOF)

Verano Holdings Corp. is based in Illinois and is one of the fastest-growing multi-state cannabis operators. The company focuses on high-margin, high-growth adult-use and medical markets. Verano operates in 13 states, including Illinois, New Jersey, and Florida. Its largest presence is in Illinois, where it operates a strong retail and cultivation footprint. Verano has over 135 dispensaries and continues to grow through both organic expansion and acquisitions. In 2024, Verano opened several new stores and launched branded products across multiple markets. The company’s strategy emphasizes premium flower, edibles, and wellness-based cannabis. It also integrates technology into its retail experience to boost customer loyalty. With growing market share and product innovation, Verano is well-positioned for future industry consolidation. Investors are watching Verano’s ability to scale while maintaining product quality and brand value.

VRNOF

Financial Performance

Verano reported $879 million in revenue for 2024, which represented a 6% decline year-over-year. Despite the revenue dip, the company maintained strong gross margins of 51%. Verano’s adjusted EBITDA was $264 million, or 30% of total revenue. The company posted a net loss of $342 million, which included non-cash impairment charges. However, Verano generated $112 million in cash from operations. This allowed it to invest $99 million in capital expenditures. The company focused on infrastructure, cultivation upgrades, and store expansion. Verano’s strong EBITDA margins and positive cash flow remain key strengths. While net losses are a concern, they are mainly non-operational. Management is focused on improving cash efficiency and scaling its retail network. Verano remains an attractive pick for investors looking for a balance of growth and margin stability.

Best Marijuana Stocks for a Potential Upswing This Year

These three U.S. cannabis leaders—Trulieve, Curaleaf, and Verano—offer broad retail footprints, solid financials, and long-term potential. In a shifting regulatory environment, scale and efficiency are vital. Investors should continue to monitor these names for bullish technical setups and use proper risk management before entering trades.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like